Found: 28
Select item for more details and to access through your institution.
Plerixafor for pathogen‐agnostic treatment in murine thigh infection and zebrafish sepsis.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 7, p. 1, doi. 10.1111/cts.13876
- By:
- Publication type:
- Article
Parkinson's disease: Still waiting for a cure.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 7, p. 1, doi. 10.1111/cts.13898
- By:
- Publication type:
- Article
Implementation of a pharmacogenetic panel‐based test for pharmacotherapy‐based supportive care in an adult oncology clinic.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 7, p. 1, doi. 10.1111/cts.13890
- By:
- Publication type:
- Article
A phase I thorough QT/QTc study evaluating therapeutic and supratherapeutic doses of avacopan in healthy participants.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 7, p. 1, doi. 10.1111/cts.13878
- By:
- Publication type:
- Article
Pharmacokinetic drug–drug interactions of JBPOS0101 mediated by cytochrome P450 3A4 and UDP‐glucuronosyltransferases.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 7, p. 1, doi. 10.1111/cts.13892
- By:
- Publication type:
- Article
Increasing acceptance of AI‐generated digital twins through clinical trial applications.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 7, p. 1, doi. 10.1111/cts.13897
- By:
- Publication type:
- Article
Ascites affects the benefit of carvedilol on patients with liver cirrhosis and esophageal and gastric varices.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 7, p. 1, doi. 10.1111/cts.13889
- By:
- Publication type:
- Article
Inflammation altered correlation between CYP2C19 genotype and CYP2C19 activity in patients receiving voriconazole.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 7, p. 1, doi. 10.1111/cts.13887
- By:
- Publication type:
- Article
Generalizability in real‐world trials.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 7, p. 1, doi. 10.1111/cts.13886
- By:
- Publication type:
- Article
Pharmacokinetics of Sofosbuvir/Velpatasvir and efficacy of an alternate‐day treatment in hemodialysis patients with chronic hepatitis C infection.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 7, p. 1, doi. 10.1111/cts.13884
- By:
- Publication type:
- Article
The effect of itraconazole, a strong CYP3A4 inhibitor, on the pharmacokinetics of the first‐in‐class ACKR3/CXCR7 antagonist, ACT‐1004‐1239.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 7, p. 1, doi. 10.1111/cts.13883
- By:
- Publication type:
- Article
Regulation in the age of calamity: Changing the regulatory paradigm.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 7, p. 1, doi. 10.1111/cts.13882
- By:
- Publication type:
- Article
Protective effect of clusterin against interleukin‐1β‐induced apoptosis and inflammation in human knee osteoarthritis chondrocytes.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 7, p. 1, doi. 10.1111/cts.13881
- By:
- Publication type:
- Article
How debunking biases in research and development decisions could lead to more equitable healthcare?
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 7, p. 1, doi. 10.1111/cts.13880
- By:
- Publication type:
- Article
Continued cancer drug approvals in Japan and Europe after market withdrawal in the United States: A comparative study of accelerated approvals.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 7, p. 1, doi. 10.1111/cts.13879
- By:
- Publication type:
- Article
Pharmacokinetics and safety of mavacamten in healthy Chinese participants with different CYP2C19 phenotypes.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 7, p. 1, doi. 10.1111/cts.13877
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 7, p. 1, doi. 10.1111/cts.13338
- Publication type:
- Article
The interactive walkway provides fit‐for‐purpose fall‐risk biomarkers in the elderly: Comparison of zolpidem and suvorexant.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 7, p. 1, doi. 10.1111/cts.13875
- By:
- Publication type:
- Article
Variational autoencoders for generative modeling of drug dosing determinants in renal, hepatic, metabolic, and cardiac disease states.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 7, p. 1, doi. 10.1111/cts.13872
- By:
- Publication type:
- Article
Using electronic health records for clinical pharmacology research: Challenges and considerations.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 7, p. 1, doi. 10.1111/cts.13871
- By:
- Publication type:
- Article
Integration of individual preclinical and clinical anti‐infective PKPD data to predict clinical study outcomes.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 7, p. 1, doi. 10.1111/cts.13870
- By:
- Publication type:
- Article
Age‐related off‐label drug prescribing in pediatric patients in South Korea and consistency of labeling compared to the United States, Europe, and Japan.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 7, p. 1, doi. 10.1111/cts.13869
- By:
- Publication type:
- Article
Alkylating agents‐induced gonadotoxicity in prepubertal males: Insights on the clinical and preclinical front.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 7, p. 1, doi. 10.1111/cts.13866
- By:
- Publication type:
- Article
PBPK‐led assessment of antimalarial drugs as candidates for Covid‐19: Simulating concentrations at the site of action to inform repurposing strategies.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 7, p. 1, doi. 10.1111/cts.13865
- By:
- Publication type:
- Article
Strategies for developing 3D printed ovarian model for restoring fertility.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 7, p. 1, doi. 10.1111/cts.13863
- By:
- Publication type:
- Article
A phase I randomized study to evaluate safety, pharmacokinetics, and pharmacodynamics of SIR2446M, a selective RIPK1 inhibitor, in healthy participants.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 7, p. 1, doi. 10.1111/cts.13857
- By:
- Publication type:
- Article
Dalzanemdor (SAGE‐718), a novel, investigational N‐methyl‐D‐aspartate receptor positive allosteric modulator: Safety, tolerability, and clinical pharmacology in randomized dose‐finding studies in healthy participants and an open‐label study in participants with Huntington's disease
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 7, p. 1, doi. 10.1111/cts.13852
- By:
- Publication type:
- Article
Reduced hepatic impairment study to evaluate pharmacokinetics and safety of zavegepant and to inform dosing recommendation for hepatic impairment.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 7, p. 1, doi. 10.1111/cts.13813
- By:
- Publication type:
- Article